Jpmorgan Chase & CO Kempharm, Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Kempharm, Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 18,265 shares of KMPH stock, worth $90,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,265
Previous 18,665
2.14%
Holding current value
$90,229
Previous $92,000
2.17%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding KMPH
# of Institutions
117Shares Held
26.1MCall Options Held
591KPut Options Held
242K-
Woodline Partners LP San Francisco, CA4.05MShares$20 Million0.18% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.92MShares$14.4 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.76MShares$13.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.7MShares$13.3 Million0.0% of portfolio
-
Altium Capital Management LP New York, NY1.7MShares$8.4 Million2.96% of portfolio
About KEMPHARM, INC
- Ticker KMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,493,600
- Market Cap $170M
- Description
- KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...